|
 |
International Conference on Alzheimer's Disease
The International Conference on Alzheimer's Disease (ICAD) is taking place in Chicago from July 26 to July 31. Many of the articles in today's news cover these sessions and press releases.
Lifestyle Factors Impact Risk of Alzheimer's Disease
(Source: ICAD/Alzheimer's Association) - A new study suggests that people who are unmarried or not living with a partner in mid-life could have an increased risk of developing Alzheimer's disease.
Experimental Amyloid Antibody Helps Remove Alzheimer's Plaques
(Source: ICAD/Lilly) - Eli Lilly announced interim results of its Phase II study of LY2062430, an investigational anti-amyloid beta monoclonal antibody for the treatment of mild to moderate Alzheimer's disease.
Results of Gammagard Phase II Clinical Trial
(Source: ICAD/Weill Cornell Medical College) - Researchers announced interim results of an ongoing Phase II clinical trial of Gammagard Intravenous Immunoglobulin (IGIV) for Alzheimer's disease.
Study on Alzheimer's Treatment in Hispanics
(Source: ICAD/PRNewswire) - Eisai and Pfizer announced study results showing that Hispanics with mild to moderate Alzheimer's disease experienced significant improvement in cognition compared to baseline after 12 weeks of treatment with Aricept. This is the first clinical trial looking at an AD prescription medication exclusively in Hispanics, and is important given the high risk of AD among this large population.
Alzheimer's Drug May Help Mild Memory Loss
(Source: ICAD/ScienceDaily) - Research investigating individuals with mild age-related memory loss indicates that early treatment is beneficial. The finding also shows how PET imaging offers researchers a tool for tracking the effectiveness of drugs prescribed to treat age-related cognitive decline.
Americans with Memory Concerns Do Not Talk to Their Doctors
(Source: PR Newswire) - Results of a survey by the Alzheimer's Foundation of America indicate that an overwhelming number of Americans with memory concerns fail to report this health issue to their doctors.
|
|